BIOMAT Database Logo BIOMAT Database Logo

Determination of Pseudomonas aeruginosa susceptibility to aminoglycosides using API and Autobac semi-automated systems. 1991

Y de Rautlin de la Roy, and G Grollier, and G Agius, and N Borion

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D011550 Pseudomonas aeruginosa A species of gram-negative, aerobic, rod-shaped bacteria commonly isolated from clinical specimens (wound, burn, and urinary tract infections). It is also found widely distributed in soil and water. P. aeruginosa is a major agent of nosocomial infection. Bacillus aeruginosus,Bacillus pyocyaneus,Bacterium aeruginosum,Bacterium pyocyaneum,Micrococcus pyocyaneus,Pseudomonas polycolor,Pseudomonas pyocyanea
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000617 Aminoglycosides Glycosylated compounds in which there is an amino substituent on the glycoside. Some of them are clinically important ANTIBIOTICS. Aminoglycoside
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial

Related Publications

Y de Rautlin de la Roy, and G Grollier, and G Agius, and N Borion
[Mechanism of susceptibility and resistance of Pseudomonas aeruginosa to aminoglycosides].
October 1991, Nihon rinsho. Japanese journal of clinical medicine,
Y de Rautlin de la Roy, and G Grollier, and G Agius, and N Borion
[Susceptibility of Pseudomonas aeruginosa to aminoglycosides: effect of free calcium and magnesium].
February 1982, Schweizerische medizinische Wochenschrift,
Y de Rautlin de la Roy, and G Grollier, and G Agius, and N Borion
Acquisition of Resistance to PEGylated branched polyethylenimine Increases Pseudomonas aeruginosa Susceptibility to Aminoglycosides.
May 2024, ChemMedChem,
Y de Rautlin de la Roy, and G Grollier, and G Agius, and N Borion
Accuracy of automated and manual systems for susceptibility testing of Pseudomonas aeruginosa to piperacillin and piperacillin-tazobactam.
January 2011, The new microbiologica,
Y de Rautlin de la Roy, and G Grollier, and G Agius, and N Borion
In-vitro susceptibility of Pseudomonas aeruginosa to old and new beta-lactam antibiotics and aminoglycosides.
June 1983, The Journal of antimicrobial chemotherapy,
Y de Rautlin de la Roy, and G Grollier, and G Agius, and N Borion
Pseudomonas aeruginosa ATCC 49189, a new quality control strain for testing P. aeruginosa susceptibility to the aminoglycosides.
November 1989, Journal of clinical microbiology,
Y de Rautlin de la Roy, and G Grollier, and G Agius, and N Borion
[Mechanism of adaptive resistance to aminoglycosides of Pseudomonas aeruginosa].
October 2003, Pathologie-biologie,
Y de Rautlin de la Roy, and G Grollier, and G Agius, and N Borion
Cross-resistance of Pseudomonas aeruginosa to ciprofloxacin, extended-spectrum beta-lactams, and aminoglycosides and susceptibility to antibiotic combinations.
August 1989, Antimicrobial agents and chemotherapy,
Y de Rautlin de la Roy, and G Grollier, and G Agius, and N Borion
Susceptibility of Pseudomonas polycolor to Pseudomonas aeruginosa bacteriophages.
September 1960, Journal of bacteriology,
Y de Rautlin de la Roy, and G Grollier, and G Agius, and N Borion
[New profile of a resistance to aminoglycosides in Pseudomonas aeruginosa].
January 1974, Pathologia et microbiologia,
Copied contents to your clipboard!